Equisetum Hyemale
Generic Name: equisetum hyemale
Brand Names:
Equisetum Hyemale
Equisetum hyemale is an OTC homeopathic product indicated for relief of bedwetting.
Overview
Equisetum hyemale is an OTC homeopathic product indicated for relief of bedwetting.
Uses
Relieves bedwetting.
Dosage
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Side Effects
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
Warnings
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
Pregnancy
If pregnant or breast-feeding, ask a health professional before use.
Frequently Asked Questions
What is Equisetum Hyemale used for?▼
Relieves bedwetting.
What are the side effects of Equisetum Hyemale?▼
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
Can I take Equisetum Hyemale during pregnancy?▼
If pregnant or breast-feeding, ask a health professional before use.
What are the important warnings for Equisetum Hyemale?▼
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
Related Medications
Dibucaine Hydrochloride
dibucaine hydrochloride
Dosage form: POWDER. Active ingredients: DIBUCAINE HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.
Arum Trip, Belladonna, Bryonia Alba, Chamomilla, Merc Sol, Morbillinum, Pulsatilla
arum trip, belladonna, bryonia alba, chamomilla, merc sol, morbillinum, pulsatilla
Uses Temporarily relieves occasional tiredness, mild body discomfort, appetite loss, sneezing, runny nose, dry cough, and irritation in the eyes, mouth, and throat.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Bevacizumab-bvzr
bevacizumab-bvzr
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Bevacizumab-bvzr is a vascular endothelial growth factor inhibitor. Bevacizumab-bvzr is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-bvzr has an approximate molecular weight of 149 kDa. Bevacizumab-bvzr is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.